| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5396826ac8c36d31e3eb53c9ef088a68 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-326
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-302 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18 |
| filingDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83712c81a4de73d7ef24bf673ef11dc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_084b839b1ec4f5de1aafd4912a7687e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d57561af2f35bcce18635259fa695aa0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e21b0309c699df7c654a6de3146bdf26 |
| publicationDate |
2018-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180005149-A |
| titleOfInvention |
Pharmaceutical composition for treating or preventing aging or agerelated diseases comprising CD9 antibody |
| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating cell aging or an aging-related disease comprising an antibody specifically binding to CD9 as an active ingredient. More particularly, the present invention relates to a pharmaceutical composition for preventing or treating CD9 antigen , The expression of CD9 was suppressed in the senescent cells to inhibit cell senescence and to reduce the atherosclerotic lesion which is a vascular disease associated with aging. Therefore, the CD9 of the present invention can be used as a biomarker composition for diseases associated with cell senescence or senescence, and can be used as a pharmaceutical composition capable of inhibiting cell senescence or preventing or treating aging-related diseases, Or as a health food composition. |
| priorityDate |
2014-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |